CALM Stock Analysis: Cal-Maine Foods | NASDAQ
Farm Products | NASDAQ, USA | Market Cap: 4.185m USD | 12M Return: -12.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 73.3M
EPS Trend: 54.9%
Qual. Beats: 0
Rev. Trend: 68.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cal-Maine Foods (NASDAQ: CALM) is a U.S. shell egg producer that grades, packages, markets, and distributes shell eggs, egg products, and prepared foods. Its product portfolio spans conventional eggs as well as specialty varieties-cage-free, organic, brown, free-range, pasture-raised, and nutritionally enhanced-sold under brands including Egg-Lands Best, Land O Lakes, Farmhouse Eggs, Sunups, Sunny Meadow, and 4-Grain. The company also offers ready-to-eat items such as hard-cooked eggs, egg wraps, and protein pancakes, and generates ancillary revenue from feed and byproducts. Customers include national and regional grocery chains, club stores, independent supermarkets, and foodservice distributors, with sales concentrated across the southwestern, southeastern, mid-western, northeastern, and mid-Atlantic U.S., plus Puerto Rico. Founded in 1957 and headquartered in Ridgeland, Mississippi, Cal-Maine is classified within the Consumer Staples sector (Packaged Foods & Meats) and is the largest producer and distributor of fresh shell eggs in the United States. The shell egg industry is characterized by commodity-like pricing volatility tied to feed costs and flock size, while demand has been gradually shifting toward cage-free and specialty eggs due to state-level legislation (such as Californias Proposition 12) and retailer-driven animal welfare commitments.
- Corn and soybean feed costs compress egg producer margins
- Avian flu outbreaks tighten shell egg supply and lift prices
- Cage-free regulations expand, driving specialty egg segment mix
| Net Income: 695.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA -4.85 > 1.0 |
| NWC/Revenue: 44.37% < 20% (prev 38.68%; Δ 5.69% < -1%) |
| CFO/TA 0.28 > 3% & CFO 892.4m > Net Income 695.0m |
| Net Debt (-1.15b) to EBITDA (1.07b): -1.07 < 3 |
| Current Ratio: 8.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.4m) vs 12m ago -3.18% < -2% |
| Gross Margin: 33.77% > 18% (prev 39.64%; Δ -5.86% > 0.5%) |
| Asset Turnover: 111.3% > 50% (prev 123.3%; Δ -11.96% > 0%) |
| Interest Coverage Ratio: 1.57k > 6 (EBIT TTM 961.8m / Interest Expense TTM 612k) |
| A: 0.49 (Total Current Assets 1.75b - Total Current Liabilities 213.0m) / Total Assets 3.14b |
| B: 0.89 (Retained Earnings 2.80b / Total Assets 3.14b) |
| C: 0.31 (EBIT TTM 961.8m / Avg Total Assets 3.11b) |
| D: 6.25 (Book Value of Equity 2.70b / Total Liabilities 432.1m) |
| Altman-Z'' = 14.76 = AAA |
| DSRI: 0.60 (Receivables 234.9m/428.4m, Revenue 3.46b/3.80b) |
| GMI: 1.17 (GM 39.64% / 33.77%) |
| AQI: 1.78 (AQ_t 0.05 / AQ_t-1 0.03) |
| SGI: 0.91 (Revenue 3.46b / 3.80b) |
| TATA: -0.06 (NI 695.0m - CFO 892.4m) / TA 3.14b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of July 20, 2026, the stock is trading at USD 88.55 with a total of 813,237 shares traded. Over the past week, the price has changed by +0.24%, over one month by +16.56%, over three months by +18.42% and over the past year by -12.23%.
Current recommended Stop Loss: 82.10 (which is 7.3% or 2.4 ATR below the current price).
Cal-Maine Foods has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold CALM.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 86.8 | -2% |
P/E Trailing = 6.1475
P/E Forward = 19.802
P/S = 1.2087
P/B = 1.55
P/EG = 2.1983
Revenue TTM = 3.46b USD
EBIT TTM = 961.8m USD
EBITDA TTM = 1.07b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.44m USD (Leases only: 1.44m)
Net Debt = -1.15b USD (calculated: Debt 1.44m - CCE 1.15b)
Enterprise Value = 3.03b USD (4.19b + Debt 1.44m - CCE 1.15b)
Interest Coverage Ratio = 1.57k (Ebit TTM 961.8m / Interest Expense TTM 612k)
EV/FCF = 4.20x (Enterprise Value 3.03b / FCF TTM 722.9m)
FCF Yield = 23.82% (FCF TTM 722.9m / Enterprise Value 3.03b)
FCF Margin = 20.88% (FCF TTM 722.9m / Revenue TTM 3.46b)
Net Margin = 20.07% (Net Income TTM 695.0m / Revenue TTM 3.46b)
Gross Margin = 33.77% ((Revenue TTM 3.46b - Cost of Revenue TTM 2.29b) / Revenue TTM)
Gross Margin QoQ = 17.88% (prev 26.95%)
Tobins Q-Ratio = 0.97 (Enterprise Value 3.03b / Total Assets 3.14b)
Interest Expense / Debt = 42.41% (Interest Expense 612k / Debt 1.44m)
Taxrate = 23.66% (215.4m / 910.7m)
NOPAT = 734.3m (EBIT 961.8m * (1 - 23.66%))
Current Ratio = 8.21 (Total Current Assets 1.75b / Total Current Liabilities 213.0m)
Debt / Equity = 0.00 (Debt 1.44m / totalStockholderEquity, last quarter 2.70b)
Debt / EBITDA = -1.07 (Net Debt -1.15b / EBITDA 1.07b)
Debt / FCF = -1.59 (Net Debt -1.15b / FCF TTM 722.9m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.35% (Net Income 695.0m / Total Assets 3.14b)
RoE = 26.11% (Net Income TTM 695.0m / Total Stockholder Equity 2.66b)
RoCE = 32.87% (EBIT 961.8m / Capital Employed (Total Assets 3.14b - Current Liab 213.0m))
RoIC = 26.67% (NOPAT 734.3m / Invested Capital 2.75b)
WACC = 6.06% (E(4.19b)/V(4.19b) * Re(6.05%) + D(1.44m)/V(4.19b) * Rd(42.41%) * (1-Tc(0.24)))
Discount Rate = 6.05% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.87 | Cagr: -1.33%
[DCF] Terminal Value 73.10% ; FCFF base≈777.3m ; Y1≈681.7m ; Y5≈550.7m
[DCF] Fair Price = 210.9 (EV 8.84b - Net Debt -1.15b = Equity 9.99b / Shares 47.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 54.86 | EPS CAGR: 38.49% | SUE: 0.50 | # QB: 0
Revenue Correlation: 68.70 | Revenue CAGR: 18.80% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-08-31): EPS=0.55 | Chg30d=+5.77% | Revisions=+25% | Analysts=1
EPS current Year (2026-05-31): EPS=7.63 | Chg30d=-3.84% | Revisions=-25% | GrowthEPS=-69.5% | GrowthRev=-30.4%
EPS next Year (2027-05-31): EPS=3.08 | Chg30d=-14.56% | Revisions=-25% | GrowthEPS=-59.6% | GrowthRev=-9.9%
[Analyst] Revisions Ratio: -17% (up=1, down=2)